IMBdx, Co.
Latest round
- Series B
Last raised
- May 2021
Total raised
- $26M
Investors
- 7
About IMBdx, Co.
, aka In My Blood Diagnostics, operates as a developer of various medical solutions to diagnose cancer by blood collection using artificial intelligence and big data. Taeyu Kim (co-CEO), Doohee Bang, and Sungtae Moon (co-CEO) are the co-founders of the company., Ltd., BSK Investment, and Partners Investment. The company specializes in the diagnosis of invisible cancers through its unique liquid biopsy technology. The firm’s core technology, the Alpha Liquid® Platform, enables the detection of various gene mutations in tumour DNA through a single blood sample. IMBDX offers a range of products under the Alpha Liquid® brand, including Alpha Liquid® Profiling, Alpha Liquid® Detect, and Alpha Liquid® Screening. The company provides clinical services in collaboration with major general hospitals in Korea. The firm offers the Alpha Liquid®100 test, which is beneficial for patients who require tumour profiling, treatment matching, response monitoring during chemotherapy, or identification of resistance genes.
Who invested in IMBdx, Co.
7 investors across 4 rounds
See all investors in IMBdx, Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about IMBdx, Co.
Who invested in IMBdx, Co.?
IMBdx, Co. has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has IMBdx, Co. raised?
IMBdx, Co. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did IMBdx, Co. last raise money?
IMBdx, Co.'s most recent round on record is a Series B, in May 2021.
What does IMBdx, Co. do?
, aka In My Blood Diagnostics, operates as a developer of various medical solutions to diagnose cancer by blood collection using artificial intelligence and big data.
Where is IMBdx, Co. headquartered?
IMBdx, Co. is headquartered in Seoul, South Korea.
Which VCs invest in companies like IMBdx, Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at IMBdx, Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like IMBdx, Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.